The present invention provides methods of preventing or inhibiting tumor metastasis in a subject by administering a therapeutically effective amount of (1) a compound from a group of enumerated compounds, or a pharmaceutically acceptable salt thereof (2) an agent that covalently modifies at least one cysteine residue of S100A4 protein or (3) an agent that inhibits the interaction between S100A4 and myosin-IIA.
